53275-49-3

Upstream product

• 31703-58-9 2-<(7-Iodo-5-heptynyl)oxy>-2H-tetrahydropyran 
• 31660-11-4 7-[(2S,3S)-3-Hydroxy-2-((E)-(R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-hept-5-ynoic acid methyl ester 
• 31753-11-4 7-[(1R,5S,6R)-6-(1,2-Bis-methanesulfonyloxy-heptyl)-3-oxo-bicyclo[3.1.0]hex-2-yl]-hept-5-ynoic acid methyl ester 
• 31767-40-5 7-[(1R,5S,6R)-6-(1,2-Dihydroxy-heptyl)-3-oxo-bicyclo[3.1.0]hex-2-yl]-hept-5-ynoic acid methyl ester 
• 31753-05-6 7-[(1R,5R,6R)-6-((Z)-Hept-1-enyl)-3-oxo-bicyclo[3.1.0]hex-2-yl]-hept-5-ynoic acid methyl ester 
• 23453-26-1 (Z)-7-[(2S,3S)-3-Hydroxy-2-((E)-(R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-hept-5-enoic acid methyl ester 
• 31776-12-2 methyl 7-iodohept-5-ynoate 

Relevant academic research and scientific papers

8β,12α,15β-PGF2 β Compounds

This invention is a group of 8-beta, 12-alpha-PG2 (prostaglandin-type) analogs having variable chain length, or methyl or phenyl substitution in the hydroxy-substituted side-chain, and processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, and labor inducement at term.

Novel compounds from coral

Novel compounds of the formula SPC1 Wherein R1 is hydrogen or methyl, R 2 is hydrogen or acetyl and the diester thereof. The compounds are useful as intermediates for preparing biologically active prostaglandins and they are useful singly as antibacterial agents.